ETFs
A
ARCT
Arcturus Therape
8.85
+0.01+0.11%After Hours: 8.91 +0.06 +0.68%19:12 04/17 EDT
OPEN/PREV CLOSE9.00/8.84
TODAY RANGE8.83-9.19
VOL499.78K
MARKET CAP251.54M
52 WEEK RANGE5.85-24.17
AVG VOL (3M)480.87K
% TURNOVER1.76%
TURNOVER--
P/E (TTM)-3.6843
% RANGE4.07%
EPS(TTM)-2.4021
P/E(FORWARD)-2.0996
P/B1.175
BVPS7.53
DIVIDEND--
P/S3.065
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP232.61M
SHARES OUTSTANDING28.42M
NEXT EARNINGS05/11-05/15
FREE FLOAT26.28M
LOT SIZE1
EX-DATE11/16/2017
News
Press Releases
Financial Reports
Profile
TipRanks·5d ago
Roth MKM Remains a Buy on Arcturus Therapeutics (ARCT)
TipRanks·04/10 04:42
Cathie Wood Buys the Dip in GeneDx (WGS): 142% Upside Ahead
Seeking Alpha·04/06 11:39
Cathie Wood's weekly moves signal shift to AI, precision medicine
Seeking Alpha·03/31 10:35
Cathie Wood's Ark Invest in broad sell-off; trims AI, crypto, internet names
TipRanks·03/26 22:55
Roth MKM Keeps Their Buy Rating on Arcturus Therapeutics (ARCT)
Benzinga·03/20 13:01
This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
Benzinga·03/20 11:48
This BP Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Friday
Benzinga·03/19 13:26
This Xponential Fitness Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
Benzinga·03/19 13:14
This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Benzinga·03/19 13:05
This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday
Benzinga·03/18 12:00
This Evommune Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Dow Jones·03/18 10:56
Arcturus Therapeutics Price Target Announced at $22.00/Share by B. Riley Securities
TipRanks·03/18 09:05
Arcturus Therapeutics initiated with a Buy at B. Riley
Same Industry
Name/Symbol
Change%
Price